< to news overview

New cut-off date for TRANSVAC call for vaccine development services

New cut-off date for TRANSVAC call for vaccine development services is set at 15 April, 2018.

TRANSVAC: European Vaccine Research and Development Infrastructure, is a collaborative infrastructure project funded by the European Commission (EC) under Horizon 2020.  The project is a joint effort of leading European groups working in the field of vaccine development, and is coordinated by the European Vaccine Initiative (EVI). TRANSVAC aims to accelerate the development of effective vaccines urgently needed to address European and global health challenges with the ultimate goal  to build an efficient and sustainable collaboration of experts and facilities to catalyse vaccine research in Europe.

TRANSVAC will offer high-quality technical services to support the development of prophylactic and therapeutic vaccines for both human and animal use. These services are not restricted to any disease in particular. Except for the few cases indicated on the website, services will be offered free of charge!  Academic and non-academic research groups, SMEs and industries can apply but only to service infrastructures outside their own country.

The call for application is launched on 15 October 2017 and will remain open for the duration of the project (until April 2022) or until all services have been exhausted. Applications can be submitted at any time and will be processed at pre-defined cut-off dates occurring every four months. The second cut-off date is on 15 April 2018. Users of the services will be selected via an independent scientific peer review process. The selected projects will then be able to commence work within TRANSVAC shortly after notification. 

For more information about the services offered by TRANSVAC, the eligibility criteria and the application process, please visit: www.transvac.org

Immuno Valley invites you to share project ideas with us! Liana Steeghs, Managing Director of Immuno Valley, joined the Board of Stakeholders of TRANSVAC early September, and although she is not involved in the judgement procedure, she can explain the call and TRANSVAC activities in more detail.